TY  - GEN
AU  - Llombart-Cussac,Antonio
AU  - Pivot,Xavier
AU  - Biganzoli,Laura
AU  - Cortes-Funes,Hernan
AU  - Pritchard,Kathleen I
AU  - Pierga,Jean-Yves
AU  - Smith,Ian
AU  - Thomssen,Christoph
AU  - Srock,Stefanie
AU  - Sampayo,Miguel
AU  - Cortes,Javier
TI  - A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial
SN  - 1532-3080
PY  - 2015///0622
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Decision Support Techniques
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Prognosis
KW  - Receptor, ErbB-2
KW  - metabolism
KW  - Risk Assessment
KW  - Risk Factors
KW  - Survival Rate
KW  - Taxoids
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.breast.2014.06.017
ER  -